A 62-year-old with chronic HFrEF (EF 30 percent) on ARNI, beta-blocker, and MRA remains NYHA II with stable BP and eGFR 70 mL/min/1.73 m². Which addit...

Question

A 62-year-old with chronic HFrEF (EF 30 percent) on ARNI, beta-blocker, and MRA remains NYHA II with stable BP and eGFR 70 mL/min/1.73 m². Which additional therapy improves morbidity and mortality?

Accepted Answer

Add an SGLT2 inhibitor

Answer

Ivabradine

Answer

Hydralazine alone

Answer

Digoxin as routine mortality therapy

Answer

Loop diuretic for mortality reduction

us-abfm MCQ (SBA): Heart Failure with Reduced Ejection Fraction

A 62-year-old with chronic HFrEF (EF 30 percent) on ARNI, beta-blocker, and MRA remains NYHA II with stable BP and eGFR 70 mL/min/1.73 m². Which additional therapy improves morbidity and mortality?